Global Intravenous(IV) Therapy and Vein Access Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Intravenous(IV) Therapy and Vein Access Market Research Report 2024
IV therapy and vein access devices market is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products.
According to MRAResearch’s new survey, global Intravenous(IV) Therapy and Vein Access market is projected to reach US$ 46480 million in 2033, increasing from US$ 35670 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intravenous(IV) Therapy and Vein Access market research.
Key companies engaged in the Intravenous(IV) Therapy and Vein Access industry include B. Braun, Baxter International, Becton Dickinson, C. R. Bard, Fresenius Kabi, Hospira(ICU Medical), Medtronic, Smiths Group and Teleflex, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Intravenous(IV) Therapy and Vein Access were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Intravenous(IV) Therapy and Vein Access market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Intravenous(IV) Therapy and Vein Access market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
B. Braun
Baxter International
Becton Dickinson
C. R. Bard
Fresenius Kabi
Hospira(ICU Medical)
Medtronic
Smiths Group
Teleflex
Segment by Type
Infusion Pumps
Implantable Ports
Intravenous Catheters
Hypodermic Needles
Other
Hospital
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Intravenous(IV) Therapy and Vein Access report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Intravenous(IV) Therapy and Vein Access market is projected to reach US$ 46480 million in 2033, increasing from US$ 35670 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intravenous(IV) Therapy and Vein Access market research.
Key companies engaged in the Intravenous(IV) Therapy and Vein Access industry include B. Braun, Baxter International, Becton Dickinson, C. R. Bard, Fresenius Kabi, Hospira(ICU Medical), Medtronic, Smiths Group and Teleflex, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Intravenous(IV) Therapy and Vein Access were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Intravenous(IV) Therapy and Vein Access market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Intravenous(IV) Therapy and Vein Access market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
B. Braun
Baxter International
Becton Dickinson
C. R. Bard
Fresenius Kabi
Hospira(ICU Medical)
Medtronic
Smiths Group
Teleflex
Segment by Type
Infusion Pumps
Implantable Ports
Intravenous Catheters
Hypodermic Needles
Other
Segment by Application
Hospital
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Intravenous(IV) Therapy and Vein Access report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source